AVR
NASDAQ · Health Care
Anteris Technologies Global
$7.74
+0.05 (+0.65%)
Financial Highlights (FY 2026)
Revenue
5.03M
Net Income
-247,604,401
Gross Margin
70.3%
Profit Margin
-4,921.3%
Rev Growth
-15.8%
D/E Ratio
—
Revenue & Net Income
Margin Trends
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Gross Margin | 70.3% | 70.3% | 49.0% | 49.0% |
| Operating Margin | -4,908.2% | -4,417.4% | 22.4% | 18.5% |
| Profit Margin | -4,921.3% | -4,675.2% | 15.0% | 17.3% |
Income Statement
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Revenue | 5.03M | 5.97M | 55.67M | 50.34M |
| Gross Profit | 3.53M | 4.19M | 27.28M | 24.67M |
| Operating Income | -246,823,131 | -263,731,233 | 12.47M | 9.31M |
| Net Income | -247,604,401 | -264,566,022 | 8.34M | 8.70M |
| Gross Margin | 70.3% | 70.3% | 49.0% | 49.0% |
| Operating Margin | -4,908.2% | -4,417.4% | 22.4% | 18.5% |
| Profit Margin | -4,921.3% | -4,675.2% | 15.0% | 17.3% |
| Rev Growth | -15.8% | -15.8% | +16.7% | +18.7% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Total Debt | 0 | 0 | 58.12M | 59.46M |
| Total Equity | — | — | 133.98M | 123.04M |
| D/E Ratio | — | — | 0.43 | 0.48 |
Cash Flow
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| EBITDA | -242,585,328 | -273,603,302 | 15.39M | 14.55M |
| Free Cash Flow | — | — | 6.68M | 6.27M |